The Biden administration has responded to the Monkeypox epidemic too slowly, say infectious disease specialists and public health campaigners, and the United States is now at risk of losing control of the illness. According to them, the reaction to Monkeypox is eerily reminiscent of the worst aspects of the early stages of the coronavirus pandemic, with highly constrained testing and a slow deployment of vaccinations resulting in a virus that is spreading unnoticed.
“Where we have fallen short is in expediting testing, making vaccinations available, and streamlining access to the greatest medicines,” said the researcher. We haven’t stopped this outbreak because all three of these areas have been bureaucratic and delayed, according to David Harvey, executive director of the National Coalition of STD Directors (NCSD).
460 cases have been reported by the Centers for Disease Control and Prevention (CDC) in 30 states, Puerto Rico, and Washington, D.C., but experts warn the figure is almost probably an underestimate since so many individuals who may be sick lack access to mass testing. Although some claim the administration’s actions may be too late, it is stepping up its response by increasing testing capacity and extending access to immunizations.